Literature DB >> 26286196

HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region.

Francesco Bussu1, Michela Sali2, Roberto Gallus3, Gianluigi Petrone4, Rosa Autorino5, Rosaria Santangelo2, Manlio Pandolfini1, Francesco Miccichè5, Giovanni Delogu2, Giovanni Almadori1, Jacopo Galli1, Maurizio Sanguinetti2, Guido Rindi4, Massimo Tommasino6, Vincenzo Valentini5, Gaetano Paludetti1.   

Abstract

BACKGROUND: Approximately 1-9 % of all head and neck squamous cell carcinomas are neck metastases from clinically undetectable primary tumors. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) are proven carcinogenic factors that are associated with oropharyngeal squamous cell carcinoma and nasopharyngeal carcinoma, respectively. In the present study, we evaluated the prevalence of these viruses in neck metastases from unknown primary squamous cell carcinoma.
METHODS: We evaluated fresh samples from a consecutive series of 22 neck dissections for metastases from unknown primary squamous cell carcinoma obtained between 2010 and 2012 at a single institution. The samples were tested for the presence of HPV E6 and E7 mRNA and EBV DNA.
RESULTS: Oncogenic viral infections were detected in 12 cases (54 % total; 2 HPV18, 5 HPV16, 2 EBV infection, and 3 EBV/HPV16 coinfections). The most frequent primarily involved neck level in our series was IIA (70 %), which had the highest prevalence of viral infection (66 %). We did not find any other significant correlations between virus detection and clinicopathologic parameters or prognosis. DISCUSSION: Neck metastasis from unknown primary squamous cell carcinoma could be another virus-related malignancy in the head and neck region, along with nasopharyngeal and oropharyngeal carcinoma. An evaluation of the impact of viral infection on patient prognosis and sensitivities to different treatment modalities could modify our prognostic assessments and treatment planning. Furthermore, virus detection would have a decisive impact on diagnostic/decisional algorithms, especially if detection methods are implemented on cytologic samples (e.g., thin prep).

Entities:  

Mesh:

Year:  2015        PMID: 26286196     DOI: 10.1245/s10434-015-4808-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What Is New in the 2017 WHO Blue Book for Tumors and Tumor-Like Lesions of the Neck and Lymph Nodes.

Authors:  Nora Katabi; James S Lewis
Journal:  Head Neck Pathol       Date:  2017-02-28

Review 2.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

3.  Beware of the dangers along the path towards the diagnosis of HPV-driven oropharyngeal squamous cell carcinoma.

Authors:  P Boscolo-Rizzo; F Bussu
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-02       Impact factor: 2.124

4.  Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.

Authors:  Tingting Xu; Chunying Shen; Ye Wei; Chaosu Hu; Yu Wang; Jun Xiang; Guo-Hua Sun; Fengtao Su; Qifeng Wang; Xueguan Lu
Journal:  Cancer Med       Date:  2020-07-27       Impact factor: 4.452

5.  Nurse-Led Consultation and Symptom Burden in Patients with Head and Neck Cancer: A Comparative Analysis of Routine Clinical Data.

Authors:  Xhyljeta Luta; Sara Colomer-Lahiguera; Rodrigo Jose Martins Cardoso; Frank Hof; Manon Savoie; Cosette Schuler; Justine Wicht; Nadia Fucina; Patricia Debarge; Françoise Ninane; Jean Bourhis; Manuela Eicher
Journal:  Cancers (Basel)       Date:  2022-02-26       Impact factor: 6.639

6.  Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.

Authors:  Chameera Ekanayake Weeramange; Zhen Liu; Gunter Hartel; Yinan Li; Sarju Vasani; Julian Langton-Lockton; Lizbeth Kenny; Luc Morris; Ian Frazer; Kai D Tang; Chamindie Punyadeera
Journal:  J Mol Diagn       Date:  2021-07-27       Impact factor: 5.341

7.  An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.

Authors:  Dayang Chen; Mengmeng Wang; Ying Guo; Wei Wu; Xiang Ji; Xiaowen Dou; Huamei Tang; Zengyan Zong; Xiuming Zhang; Dan Xiong
Journal:  Cancer Med       Date:  2021-07-27       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.